Coste Catherine
SEC CIK 1821432 · EDGAR
BoughtSold
Most active insiders at BLFS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners Master Fund, L.P. | 10% | — | $28.12M |
| 2 | Casdin Partners GP, LLC | 10% | — | $21.41M |
| 3 | DE GREEF RODERICK | Pres, CEO, Dir | — | $3.61M |
| 4 | Foster Karen A. | Chief Quality, Ops | — | $2.07M |
| 5 | Wichterman Troy | CFO | — | $873.5K |
| 6 | DuRoss Amy | Dir | — | $305.7K |
| 7 | Mathew Aby J. | EVP, CSO | — | $65.2K |
| 8 | GOSWAMI JOYDEEP | Dir | — | $48.3K |
| 9 | Aebersold Sarah | CHRO | — | $45.0K |
| 10 | Berard Todd | CMO | — | $42.4K |
| 12 | Coste Catherine | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | BLFS | BIOLIFE SOLUTIONS INC | Coste Catherine | Dir | A - Grant | — | +8,170 | 13.9K | +143% | — | |
| 2025-03-20 | 2025-03-18 | BLFS | BIOLIFE SOLUTIONS INC | Coste Catherine | Dir | A - Grant | — | +5,701 | 5,701 | New | — | |
| 2024-12-17 | 2024-12-13 | BMRA | BIOMERICA INC | Coste Catherine | Dir | A - Grant | $0.31 | +85.0K | 128.8K | +194% | +$26.4K | |
| 2023-01-30 | 2023-01-26 | BMRA | BIOMERICA INC | Coste Catherine | Dir, Audit Committee COB | P - Purchase | $2.96 | +2,190 | 43.8K | +5% | +$6,482 |
Purchase Sale Sale after option exercise All abbreviations